Goldspire™: A Biologic-Device Combination Immunotherapy that Induces Preclinical Anti-Tumor Responses Against Multiple Solid Tumors Shows Clinical Activity in Glioblastoma

Time: 9:30 am
day: Conference Day One

Details:

  • Utilizing a biodiffusion chamber releasing tumor antigens and an IGF1R antisense for effective treatment of glioblastoma
  • Realizing the platform configuration to maximize immunogenic cell death
  • Exploring long-term survival and immunity of glioblastoma patients receiving individualized immunotherapy

Speakers: